Figure 7.
Effects of MDA7 administered by i.p. injection on tactile allodynia in a paclitaxel-induced neuropathic pain model in rats (n=8 per group). MDA7 dose-dependently attenuated tactile allodynia in this model, as shown by an increase in the percentage maximal possible effect (%MPE) withdrawal threshold area under the curve (AUC). *P⩽0.05 compared with 10 and 15 mg kg−1 of MDA7 (ANOVA followed by Tukey–Kramer test for multiple group comparison). +P⩽0.05, P<0.05 compared with 15 mg kg−1 of MDA7 (ANOVA followed by Tukey–Kramer test for multiple group comparison).